Industry Headlines: Page 364

MJardin Group Announces Investment in DNA Genetics

MJardin’s investment was part of a $35 million financing completed by DNA Genetics last week.

Lau Ola LLC Announces Company Rebrand, Changes Name to Big Island Grown Dispensaries

The new brand reflects local ties and provides opportunity for growth.

Cresco Labs Begins Trading on the Canadian Securities Exchange Under Ticker Symbol 'CL'

A new investors website launched at investors.crescolabs.com.

Provacan CBD Becomes Kosher-Certified Cannabis Product in Britain

The UK CBD oil provider has become certified as kosher by the Kosher London Beth Din.

FSD Pharma Achieves Over 4 Billion Shares Traded in First 6 Months

The company has traded over four billion Class B subordinate voting shares in its first six months of trading on the Canadian Securities Exchange.

Robert Sampson Announces Holdings in Cresco Labs Inc.

Sampson holds and controls his shares of the company for investment purposes only.

Canopy Growth and Canopy Rivers Announce Completion of TerrAscend Restructuring

The companies have announced the closing of the previously announced restructuring transaction with TerrAscend Corp.

Fewer Than 600 Patients Get Medical Cannabis Under Restrictive Texas Law

One year after the first legally grown marijuana plants were harvested in Texas for their medicinal oils, fewer than 600 patients have seen any benefit.

Utah Banks, Credit Unions Wary of Medical Marijuana Money

A Utah banking industry representative said the funds cannot go to banks, even when the state says medical marijuana is legal.

Credit Union to Work With Alaska Marijuana Business in Pilot Program

That pilot program will offer services to marijuana businesses that include accounts, deposits and withdraws, and eventually hope to set up payroll operations.

U.S. Lawsuit Puts Cannabis Patent Claims to the Test

This year, the U.S. Patent and Trademark Office has issued 39 patents containing the words cannabis or marijuana in their summaries, up from 29 in 2017 and 14 in 2016.

FSD Pharma Reports Positive Q3 Results

The company has reported its financial and operational results for the third quarter of fiscal 2018, ended Sept. 30.

Previous Page

Page 364 of 656

Next Page